Search - tctmd.com

Displaying 21 - 32 of 32

Sort: Relevancy | Date

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

News Daily News

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

Michael O'Riordan

April 27, 2017

Sex, Race Disparities in High Blood Pressure Begin to Emerge Early in Life

News Daily News

Sex, Race Disparities in High Blood Pressure Begin to Emerge Early in Life

April 21, 2017

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

News Conference News ACC 2017

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

March 23, 2017

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

News Conference News ACC 2017

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

March 18, 2017

Matthew Feinstein, MD

News Featured Fellow

Matthew Feinstein, MD

Yael L. Maxwell

February 24, 2017

Increased Radial Access Is Not Associated With Worse Femoral Outcomes for PCI in UK

News Daily News

High-Volume Transradial PCI Centers Do Not Lose Femoral Skills: BCIS Registry

Michael O'Riordan

February 17, 2017

AHA Wades Into Conversation Over Periprocedural Use of Non-Vitamin K Antagonist Oral Anticoagulants

News Daily News

AHA Wades Into Conversation Over Periprocedural Use of Non-Vitamin K Antagonist Oral Anticoagulants

Yael L. Maxwell

February 13, 2017

Clot in Transit: Diagnosis and Treatment

Presentation ISET 2017

Clot in Transit: Diagnosis and Treatment

Presenter: John Moriarty

February 04, 2017

ACC Leadership Speaks Out on What US Political Shifts Mean for Cardiologists

News Daily News

ACC Leadership Speaks Out on What US Political Shifts Mean for Cardiologists

January 30, 2017

News Daily News

First High-Sensitivity Troponin Assay Finally Comes to the United States

January 24, 2017

News Daily News

Robert Califf Leaving Post as FDA Commissioner

January 13, 2017

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.